Telephone
61.3.8347.5000
Address
39 Pinnacle Road Altona North, Victoria (VIC) 3025
Description
Clover Corp. Ltd. engages in research and product development of functional food and infant nutrition ingredients. It also focuses on the sale of natural oils and production of encapsulated powders. Its products include Docosahexaenoic acid oils and powders, and Microencapsulation. The company was founded by Guy Hamish Drummond in 1988 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.7 - 1.47
Trade Value (12mth)
AU$11,223.00
1 week
6.02%
1 month
2.92%
YTD
-27.87%
1 year
-29.32%
All time high
3.31
EPS 3 yr Growth
-50.500%
EBITDA Margin
13.60%
Operating Cashflow
$7m
Free Cash Flow Return
9.00%
ROIC
8.30%
Interest Coverage
14.90
Quick Ratio
2.80
Shares on Issue (Fully Dilluted)
167m
HALO Sector
Healthcare
Next Company Report Date
20-Sep-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 19 |
Clover Corporation - Select Equities presentation
×
Clover Corporation - Select Equities presentation |
31 October 08 |
Annual Report/Notice of Annual General Meeting
×
Annual Report/Notice of Annual General Meeting |
30 October 13 |
2013 Annual Report
×
2013 Annual Report |
30 October 07 |
Annual Report/Notice of Annual General Meeting
×
Annual Report/Notice of Annual General Meeting |
30 November 12 |
2012 AGM - Chairman\'s Address and MD Presentation
×
2012 AGM - Chairman\'s Address and MD Presentation |
29 September 08 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 October 14 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
29 October 12 |
Annual Report / Notice of Annual General Meeting
×
Annual Report / Notice of Annual General Meeting |
29 November 22 |
Notification regarding unquoted securities - CLV
×
Notification regarding unquoted securities - CLV |
29 November 13 |
2013 AGM - Chariman\'s Address and MD Presentation
×
2013 AGM - Chariman\'s Address and MD Presentation |
28 October 21 |
Clover Corporation Select Equities Presentation 28 Oct 21
×
Clover Corporation Select Equities Presentation 28 Oct 21 |
28 November 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
28 November 14 |
2014 AGM - Chairman's Address and CEO Presentation
×
2014 AGM - Chairman's Address and CEO Presentation |
28 November 06 |
MD'S Presentation 2006 AGM
×
MD'S Presentation 2006 AGM |
28 April 22 |
Payment of FY22 Interim Dividend
×
Payment of FY22 Interim Dividend |
27 September 10 |
Amendment to 2010 Annual Report
×
Amendment to 2010 Annual Report |
27 October 22 |
Clover's Premneo improves IQ of children
×
Clover's Premneo improves IQ of children |
27 October 11 |
Annual Report to shareholders
×
Annual Report to shareholders |
27 November 23 |
Notification regarding unquoted securities - CLV
×
Notification regarding unquoted securities - CLV |
27 November 23 |
Notification of cessation of securities - CLV
×
Notification of cessation of securities - CLV |
27 November 23 |
Change of Director's Interest Notice - Appendix 3Y
×
Change of Director's Interest Notice - Appendix 3Y |
27 November 17 |
Results of 2017 Annual General Meeting
×
Results of 2017 Annual General Meeting |
27 November 15 |
2015 AGM - Chairman's Address and CEO Presentation
×
2015 AGM - Chairman's Address and CEO Presentation |
27 April 23 |
Payment of FY23 Interim Dividend
×
Payment of FY23 Interim Dividend |
26 September 23 |
Clover 2023 Appendix 4E
×
Clover 2023 Appendix 4E |
26 September 23 |
Clover 2023 Full Year Results Market Announcement
×
Clover 2023 Full Year Results Market Announcement |
26 September 23 |
Clover 2023 Annual Report
×
Clover 2023 Annual Report |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.